Proposed Increased Charges for Female Sterilisation Surgery – Briefing Paper
Purpose
The Minister for Health and Social Services has agreed in principle to the proposed increased charges to be made to service users who request the procedure of Sterilisation.
Background
At present, Health and Social Services (H&SS) charge the service user £125.00 for this procedure. The charge has not been increased for at least 7 years, and includes a payment of £83.00 to the surgeon undertaking the procedure. The service continues to experience a high demand and needs to respond accordingly whilst remaining within the existing budget.
Female Sterilisation – Proposed Increase in Charge
The National Health Service provides this procedure at an approximate cost to the service user of £1,400.00.
If this service is provided privately the current charge levied by HSSD is £1,045.00. These charges are currently under review, and do not include pre and post surgery outpatient appointments, Theatre equipment and supplies, and Semen Analysis. Insurance companies do not cover this charge.
The table below provides a financial breakdown of the costs of this service to Jersey H&SS.
Initial outpatient appointment | £59.20 |
Blood Test | £56.25 |
Semen Analysis | £105.24 |
Surgery (In Day Surgery Unit) | £651.18 |
Follow up appointment | £59.20 |
Total | £1,162.00 |
The proposed charge by H&SS for Female Sterilisation is £1,162. Yearly increase should occur in line with inflation
Scope
Sterilisation is a surgical procedure that permanently removes an individual’s fertility, normally tubal occlusion in women. This is carried out under General Anaesthetic usually as a day case. H&SS will fund in exceptional circumstances;
Family in receipt of Income Support
Any medical or obstetric condition which would make the a pregnancy dangerous to the health of the woman.
Estimated Financial Impact of Increased Charges
The aim is to introduce an increased charge to service users, reflecting the cost to H&SS. The financial objective for introducing this increased charge is to ensure the cost recovery of service provision to non-exempt service users.
H&SS provided this service to 33 patients in 2008, 31 in 2009 and 23 in 2010. If demand should reduce as a result of the proposed charge, other forms of contraception are available within H&SS. It is important to note that this charge will fall below the current charge of the National Health Service, so it is unlikely that the service user will choose to undergo the procedure outside Jersey.
Additional Information
H&SS policy for Female Sterilisation has been developed and is available on HSSNet.
Patient Information Leaflets have been produced and are in use in outpatient Gynaecology clinics.
A Female Sterilisation counselling list has been developed to ensure patients are well informed prior to agreeing to surgery. This is in use in outpatient Gynaecology clinics.
Recommendation
The proposed increased charge for Female Sterilisation should be introduced to meet HSS cost of providing the service.
Angela Body
Director of Operations
I